Recudon 2.5 mg/ml + 0.125 mg/ml Solution for Injection for Horses and Dogs
Active ingredients: Fenpipramide Hydrochloride, Levomethadone Hydrochloride
Form
Injection
Species
Manufacturer
Alfasan Nederland B.V.
VMD MA No.
36408/3017
The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Fenpipramide Hydrochloride +...
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Recudon 2.5 mg/ml + 0.125 mg/ml Solution for Injection for Horses and Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.
Corresponding to: Per 100 kg bodyweight: 4.0-6.0 ml veterinary medicinal product.
Use for premedication in combination with xylazine, romifidine or detomidine
The lower end of this dose-range should be used when the veterinary medicinal
product is used in combination with one of these substances. Assessment of the
combination to be used should be done by the treating veterinarian based on the
purpose of treatment and the physical characteristics of the individual patient. All
anaesthetics used for induction or maintenance of anaesthesia should be administered
guided by effect.
Dogs:
Analgesia
0.2-1.0 mg levomethadone-HCL / 0.01-0.05 mg fenpipramide-HCL per kg bodyweight
intravenously or intramuscularly.
Corresponding to: Per 10 kg bodyweight: 0.8- 4.0 ml veterinary medicinal product.
Levomethadone is approximately twice as potent as the methadone racemate. The
dosage should generally be half of the dose of methadone.
Doses higher than 0.5 mg levomethadone-HCL per kg should only be administered
after thorough assessment of the severity of the pain, individual differences in pain
sensitivity and the general condition of the dog.
When the volume to be injected exceeds 5 ml, consideration should be given by the
responsible veterinarian to divide the intramuscular injection over multiple injections
sites or choose the intravenous route of administration. The total dose in dogs should
not exceed 25 ml.
Use for premedication in combination with xylazine, medetomidine or
dexmedetomidine
The lower end of this dose-range should be used when the veterinary medicinal
product is used in combination with one of these substances. Assessment of the
combination to be used should be done by the treating veterinarian based on the
purpose of treatment and the physical characteristics of the individual patient. All
anaesthetics used for induction or maintenance of anaesthesia should be administered
guided by effect.
Before administration the body weight should be accurately determined. The vial can
be broached up to 10 times. The user should choose the most appropriate vial size
according to the target species to be treated.
Do not use in animals with severe liver or renal dysfunction.
Do not use in animals suffering from epileptic or strychnine seizures or tetanus
Do not use in cases of known hypersensitivity to any of the active substances or
excipients.
Horses:
FrequencyAdverse eventUndetermined frequency (cannot be
estimated from the available data)
Respiratory depression, Decreased
body temperature, Bradycardia,
Excitation
, Constipation.
Only at high doses
2.
The presence or absence of pain influences the response to opioids. Horses in pain
may show no adverse reactions to doses which would cause excitement in normal
animals
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder (or its local representative) or the national
competent authority via the national reporting system. See also section ‘contact
details’ of the package leaflet for respective contact details.
monitored regularly to ensure sufficient efficacy for the desired duration of effect.
For methadone it has been described that Greyhounds may require higher doses than
other breeds to achieve efficacious plasma levels. No corresponding information is
available on the requirement for higher doses of specifically levomethadone in
greyhounds, when compared to other breeds.
Special precautions for safe use in the target species
It is recommended that dogs are fasted for 12 hours prior to administration of the
veterinary medicinal product. In dogs, this veterinary medicinal product should be
injected very slowly when used intravenously. Restlessness and howling of the
animals during the injection are signs of underdosing, so the injection should be
continued.
Because the effects last for several hours, the animal should be protected from
acoustic stimuli, and should be kept warm and dry until fully recovered.
Adequate oxygenation should be ensured during treatment, treated animals should be
monitored regularly, including examination of heart rate and respiratory rate.
Use cautiously in animals with head injuries, as the effect of an opioid on head injury is
dependent on the type and severity of the injury and the respiratory support supplied.
As methadone is metabolised by the liver, its intensity and duration of action may be
affected in animals with impaired liver function.
In case of renal, cardiac or hepatic dysfunction, or shock, there may be greater risk
associated with the use of the veterinary medicinal product.
For maximum intramuscular injection volume per injection site see section 3.9:
administration route and dosage.
It should be noted that antagonising the levomethadone component in the veterinary
medicinal product can lead to an overhang by fenpipramide hydrochloride, which can
lead to tachycardia, for more information see section 3.10 Symptoms of overdose.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Levomethadone is an opioid and can cause respiratory depression following
accidental self-injection. Prolonged dermal exposure may also cause adverse effects.
(Levo)Methadone may harm the unborn child. The veterinary medicinal product should
not be administered by pregnant women.
Avoid skin, eye and mouth contact. In cases of spillage onto the skin, or splashing into
the eyes, wash immediately with large amounts of water. Remove contaminated
clothes.
People with known hypersensitivity to levomethadone and/or parabens should avoid
contact with the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet to the physician but DO NOT DRIVE as sedation may occur.
ADVICE TO DOCTORS: Levomethadone is an opioid whose toxicity may cause
clinical effects including respiratory depression or apnoea, sedation, hypotension and
coma. When respiratory depression occurs controlled ventilation should be initiated.
Administration of the opioid antagonist naloxone to reverse the symptoms is
recommended.
Page 3 of 7Special precautions for the protection of the environment:
Not applicable.
nervous system inhibitors and substances that cause respiratory depression.
Concomitant or subsequent use of the veterinary medicinal product with
buprenorphine may lead to lack of efficacy.
The effect of metoclopramide on accelerating gastric emptying is reduced.
FrequencyAdverse eventUndetermined frequency (cannot be
estimated from the available data)
Respiratory depression, Panting,
Irregular breathing, Decreased body
temperature, Bradycardia
,
Increased sensitivity to sound,
Constipation, Vomiting.
This veterinary medicinal product does not require any special temperature storage
conditions.
Milk: Not authorised for use in horses producing milk for human
consumption.
4.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Related Conditions
Other Products Containing Fenpipramide Hydrochloride
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
We may earn a small commission if you purchase through these links, at no extra cost to you.
Related Medications
Alvegesic Vet. 10 mg/ml Solution for Injection for Horses, Dogs and Cats
POM-VButorphanol
Alvegesic Vet. 10 mg/ml Solution for Injection for Horses, Dogs and Cats
POM-VButorphanol
Bupaq 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
POM-VBuprenorphine
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.